Using a recent survey on the adoption of AI/ML conducted by the Tufts CSDD as context, pharma leaders discussed how they are using these technologies to optimize trial execution.

From data leakage to IP loss, AI risks are growing. Explore how tech CEOs are tackling 2025's top AI challenges with ethical ...

Higher education can navigate AI transformation by prioritizing people, addressing technological change through empathetic ...

NTT DATA, a global leader in digital business and technology services, today launched its new report, “The AI Security Balancing Act: From Risk to Innovation,” highlighting the opportunities and risks ...

Recent analysis explores AI's momentum in drug development, showcasing rapid adoption and significant time savings, despite ...

Organizations must retrofit their workforce, processes and leadership for AI rather than forcing them to adapt to rigid ...

Only 18% of respondents in Thailand have adopted artificial intelligence (AI), while 73% are still considering it, citing ...

The ISG State of the Agentic AI Market report findings will be presented at the ISG AI Impact Summit, June 23–24 at the ...

Without human engagement, AI systems are vulnerable to misaligned objectives, hidden biases and stagnation. That’s why it’s ...

Background The integration of artificial intelligence (AI) into critical care offers significant potential to enhance early ...

Preeti Lobana, Google India's head, emphasizes the importance of trust and security to sustain India's booming digital ...